Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03TYT
|
||||
Former ID |
DIB011170
|
||||
Drug Name |
PF-03800130
|
||||
Synonyms |
Dual dopamine D2 partial agonist/serotonin reuptake inhibitor (schizophrenia/bipolar disorder), Pfizer
|
||||
Indication | Bipolar disorder [ICD9: 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300; ICD10:F31, F40-F42] | Investigative | [1] | ||
Company |
Pfizer Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
c1ccc(N2CCN(CC2)CCCOc2nc3c(cc2)ccc(=O)[nH]3)c2c1CCC2
|
||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Agonist | [1] | |
KEGG Pathway | Rap1 signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Dopaminergic synapse | |||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Alcoholism | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathway | |||||
Reactome | Dopamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 215). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.